Cargando…

Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand

INTRODUCTION: With virologic suppression and longer life expectancy, older adults with HIV (OAHIV) are at risk for neurocognitive impairment (NCI). This study investigated neurocognitive performance, quality of life (QOL) and the association between OAHIV determinants. METHODS: This cross‐sectional...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurpibul, Linda, Sripan, Patumrat, Tangmunkongvorakul, Arunrat, Chaikan, Wilawan, Sarachai, Saowalak, Srithanaviboonchai, Kriengkrai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522635/
https://www.ncbi.nlm.nih.gov/pubmed/36176022
http://dx.doi.org/10.1002/jia2.25983
_version_ 1784800102800424960
author Aurpibul, Linda
Sripan, Patumrat
Tangmunkongvorakul, Arunrat
Chaikan, Wilawan
Sarachai, Saowalak
Srithanaviboonchai, Kriengkrai
author_facet Aurpibul, Linda
Sripan, Patumrat
Tangmunkongvorakul, Arunrat
Chaikan, Wilawan
Sarachai, Saowalak
Srithanaviboonchai, Kriengkrai
author_sort Aurpibul, Linda
collection PubMed
description INTRODUCTION: With virologic suppression and longer life expectancy, older adults with HIV (OAHIV) are at risk for neurocognitive impairment (NCI). This study investigated neurocognitive performance, quality of life (QOL) and the association between OAHIV determinants. METHODS: This cross‐sectional study was conducted in OAHIV aged ≥ 50 years on antiretroviral treatment at community hospitals in Northern Thailand between September and November 2020. The Montreal Cognitive Assessment Thai Version (MoCA‐T) and the Thai‐validated Medical Outcomes Study HIV (MOS‐HIV) were used. NCI was defined as MoCA‐T scores <25: 16–24 for amnestic mild cognitive impairment (aMCI) and <16 for dementia. For QOL, higher scores meant better QOL; a physical health summary T‐score ≥50 was defined as good QOL. RESULTS: Overall, 269 OAHIV were enrolled; 59% were female and 99% had virologic suppression. The current median age was 61.8 years (interquartile range [IQR] 58.9–65.7). The median duration of antiretroviral treatment was 10.5 years (IQR 8.5–13.5). The current median CD4 count (234 tested) was 484 cells/mm(3) (IQR 339–634), and 99% had plasma HIV RNA <40 copies/ml (229 tested). The median MoCA‐T score was 20.0 (IQR 16.3–23.0). There were 234 OAHIV (87.3%) with NCI: 182 (67.9%) with aMCI and 52 (19.4%) with dementia. A hundred and ninety (70.6%) had good QOL. Bivariate analysis revealed no correlation between MoCA‐T scores and QOL. Multivariable linear regression analysis revealed that MoCA‐T score was associated with older age (r = –0.144, p = 0.002), lower education (r = 0.629, p < 0.001), lower income (r = 0.797, p = 0.040) and shorter treatment duration (r = 0.189, p = 0.006). CONCLUSIONS: The vast majority of OAHIV with virologic suppression had NCI. Approximately two‐thirds had a mild impairment and one‐fifth had dementia. Neurocognitive performance and QOL were not correlated. Addressing mild NCI would enable more targeted monitoring. Early intervention and support could minimize functional impairment with increased age.
format Online
Article
Text
id pubmed-9522635
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95226352022-10-05 Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand Aurpibul, Linda Sripan, Patumrat Tangmunkongvorakul, Arunrat Chaikan, Wilawan Sarachai, Saowalak Srithanaviboonchai, Kriengkrai J Int AIDS Soc Research Articles INTRODUCTION: With virologic suppression and longer life expectancy, older adults with HIV (OAHIV) are at risk for neurocognitive impairment (NCI). This study investigated neurocognitive performance, quality of life (QOL) and the association between OAHIV determinants. METHODS: This cross‐sectional study was conducted in OAHIV aged ≥ 50 years on antiretroviral treatment at community hospitals in Northern Thailand between September and November 2020. The Montreal Cognitive Assessment Thai Version (MoCA‐T) and the Thai‐validated Medical Outcomes Study HIV (MOS‐HIV) were used. NCI was defined as MoCA‐T scores <25: 16–24 for amnestic mild cognitive impairment (aMCI) and <16 for dementia. For QOL, higher scores meant better QOL; a physical health summary T‐score ≥50 was defined as good QOL. RESULTS: Overall, 269 OAHIV were enrolled; 59% were female and 99% had virologic suppression. The current median age was 61.8 years (interquartile range [IQR] 58.9–65.7). The median duration of antiretroviral treatment was 10.5 years (IQR 8.5–13.5). The current median CD4 count (234 tested) was 484 cells/mm(3) (IQR 339–634), and 99% had plasma HIV RNA <40 copies/ml (229 tested). The median MoCA‐T score was 20.0 (IQR 16.3–23.0). There were 234 OAHIV (87.3%) with NCI: 182 (67.9%) with aMCI and 52 (19.4%) with dementia. A hundred and ninety (70.6%) had good QOL. Bivariate analysis revealed no correlation between MoCA‐T scores and QOL. Multivariable linear regression analysis revealed that MoCA‐T score was associated with older age (r = –0.144, p = 0.002), lower education (r = 0.629, p < 0.001), lower income (r = 0.797, p = 0.040) and shorter treatment duration (r = 0.189, p = 0.006). CONCLUSIONS: The vast majority of OAHIV with virologic suppression had NCI. Approximately two‐thirds had a mild impairment and one‐fifth had dementia. Neurocognitive performance and QOL were not correlated. Addressing mild NCI would enable more targeted monitoring. Early intervention and support could minimize functional impairment with increased age. John Wiley and Sons Inc. 2022-09-29 /pmc/articles/PMC9522635/ /pubmed/36176022 http://dx.doi.org/10.1002/jia2.25983 Text en © 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Aurpibul, Linda
Sripan, Patumrat
Tangmunkongvorakul, Arunrat
Chaikan, Wilawan
Sarachai, Saowalak
Srithanaviboonchai, Kriengkrai
Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
title Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
title_full Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
title_fullStr Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
title_full_unstemmed Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
title_short Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
title_sort neurocognitive performance and quality of life of older adults with hiv on antiretroviral treatment in northern thailand
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522635/
https://www.ncbi.nlm.nih.gov/pubmed/36176022
http://dx.doi.org/10.1002/jia2.25983
work_keys_str_mv AT aurpibullinda neurocognitiveperformanceandqualityoflifeofolderadultswithhivonantiretroviraltreatmentinnorthernthailand
AT sripanpatumrat neurocognitiveperformanceandqualityoflifeofolderadultswithhivonantiretroviraltreatmentinnorthernthailand
AT tangmunkongvorakularunrat neurocognitiveperformanceandqualityoflifeofolderadultswithhivonantiretroviraltreatmentinnorthernthailand
AT chaikanwilawan neurocognitiveperformanceandqualityoflifeofolderadultswithhivonantiretroviraltreatmentinnorthernthailand
AT sarachaisaowalak neurocognitiveperformanceandqualityoflifeofolderadultswithhivonantiretroviraltreatmentinnorthernthailand
AT srithanaviboonchaikriengkrai neurocognitiveperformanceandqualityoflifeofolderadultswithhivonantiretroviraltreatmentinnorthernthailand